Evidence map›Paper›PMID 9874671›Full record

ArticleClinical and diagnostic laboratory immunology1999

Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274.

T Ueyama, X X Gu, C M Tsai, A B Karpas, D J Lim

Open access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

T UeyamaLaboratory of Immunology, National Institute on Deafness and Other Communication Disorders, Rockville, Maryland 20850, USA.
X X Gu
C M Tsai
A B Karpas
D J Lim
National Institute on Deafness and Other Communication Disorders · USFood and Drug Administration · THHealth and Human Development (2HD) Research Network · CM

Funding

VACCINE DEVELOPMENT OF NONTYPEABL HAEMOPHILUS INFLUENZAEZ01DC000019 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GU, XIN-XING · 1994 to 2008
$1.5M
Vaccine Development Of Nontypeable Haemophilus influenzae/Moraxella catarrhalisZIADC000019 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GU, XIN-XING · 2009 to 2010
$1.3M
PATHOGENESIS/IMMUNOBIOLOGY OF NONTYPEABLE HAEMOPHILUS INFLUENZAE OTITIS MEDIAZ01DC000020 · NIDCD · DEAFNESS &OTHER COMMUNICATION DISORDERS · PI GU, XIN-XING XING · 1994 to 2001
–
6 · The paper itself

Abstract

Twenty-one murine monoclonal antibodies (MAbs) were induced by nontypeable Haemophilus influenzae (NTHi) 9274. Nineteen MAbs were specific for the lipooligosaccharide (LOS) as determined by enzyme-linked immunosorbent assay (ELISA) and Western blot analysis. When the MAbs were assayed with five LOS prototype strains by ELISA, all bound to strain 3198 LOS (type III), while six of the MAbs were also reactive with LOSs from strain 1479 (type I), 5657 (type IV), or 7502 (type V). Ten MAbs had complement-mediated bactericidal activity, and three MAbs were opsonophagocytic against the homologous strain. Five LOS MAbs with different specificities were used to analyze 155 NTHi clinical isolates from the United States and from Japan. These isolates were classified into nine groups by ELISA. Only four isolates (2.6%) were not recognized by any of the five MAbs. Most of the isolates (91.6%) were in four groups which bound three of the five MAbs. One of three MAbs, 6347C11, had strong activity against the homologous strain and was also bactericidal to 45 clinical isolates (29%) which belonged to the four common patterns (25 belonged to pattern 1). These data indicate that these MAbs can be used for LOS typing in which almost all NTHi strains can be typed according to the LOS antigenicity. Among NTHi, at least one conserved LOS epitope which is a target of bactericidal antibodies exists. We conclude that strain 9274 LOS, which is the target for bactericidal antibodies, is a candidate for LOS-based NTHi vaccines.

Indexed as

Antibodies, MonoclonalAnimalsAntibodies, BacterialAntibody SpecificityBacterial Typing TechniquesBlotting, WesternChildEnzyme-Linked Immunosorbent AssayHaemophilus InfectionsHaemophilus influenzaeHaemophilus VaccinesHumansLipopolysaccharidesMiceOtitis MediaVaccines, ConjugateAntibodies, BacterialAntibodies, MonoclonalHaemophilus Vaccineslipid-linked oligosaccharidesLipopolysaccharidesVaccines, Conjugate

Identifiers

PMID9874671
PMCPMC95667
OpenAlexW2149242410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.